美国 FDA 暂时搁置 Intellia 的两项基因编辑治疗试验

路透中文
Oct 30
美国 FDA 暂时搁置 <a href="https://laohu8.com/S/NTLA">Intellia</a> 的两项基因编辑治疗试验

路透10月29日 - Intellia Therapeutics NTLA.O周三表示,美国食品和药物管理局已暂停其两项后期试验,这两项试验是针对一种可损害心脏和神经的罕见疾病的实验性基因编辑疗法。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10